Treating Rosacea with Macrolides (biaxin, zithromax, dynabac, rulid, surlid)
Macrolide Antibiotics offer alternative treatment options to the well known tetracycline antibiotics. In recent years good studies have shown that some of these macrolides are safe and effective in...
View ArticleOxytetracycline (Terramycin) joins low dose antibiotics
There has been a lot of publicity lately about Oracea, which is a low dosage, sustained release 40mg form of doxycyline. Oracea was born out of the expiration of the patent on periostat – a twice a day...
View ArticleSIBO Eradication Clears Rosacea (Rifaximin/Xifaxan): are you serious ?
This sort of abstract just make me shake my head. If you read quickly you will think that this abstract suggests that Small Intestinal Bacterial Overgrowth (SIBO) causes rosacea. What this abstract is...
View ArticleOracea is Not an Antibiotic, Apparently
This claim from the Oracea web site caught my eye. Oracea is NOT an antibiotic. A bit of poetic marketing license perhaps? Oracea is a 40mg dose of the antibiotic doxycycline, which is a member of the...
View ArticleStaphefekt: New antibiotic topical kills MRSA
Lots of mainstream media attention this week relating to a new type of antibiotic that is able to kill that increasingly resistant bacteria MRSA. The small patient trial was able to demonstrate that...
View ArticleGladskin Rosacea Cream and Gel, Staphefekt in a topical
Seeking to create products based on the recently publicised MRSA-killing topical Staphefekt are some topical creams to treat rosacea, acne, eczema and general skin irritation. The company that reported...
View ArticlePromius files NDA for modified release tetracycline DFD-09
Promius Pharma, a subsidiary of Dr. Reddy’s Laboratory has filed a New Drug Application for a modified release tetracycline for the treatment of rosacea. Promius is calling their new drug DFD-09....
View ArticleBioPharmX developing topical Minocycline Gel 1%
A phase 2 trial for a topical minocycline gel for the papules and pustules of rosacea has just been listed. BiopharmX, the sponsors of the trial, suggest that the product BPX-04 has “good tolerability...
View ArticleZilxi 1.5% Topical Minocycline Foam for rosacea lesions
Zilxi, 1.5% Topical Minocycline Foam has been approved for the treatment of the papules and pustules of rosacea in adults. From the Press Release “ZILXI (minocycline) topical foam, 1.5% is a topical...
View ArticleZilxi to launch at $485 for 30gm canister
The publicity around the launch for Zilxi, the new 1.5% topical minocycline based treatment for rosacea contains confirmation that the list price for a 30gm prescription will be $485. Now known as VYNE...
View Article
